The largest database of trusted experimental protocols

6 protocols using proglumide

1

High-LCT Diet Tolerance in GIP KO Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Saline (1.0 mL/kg body weight), MCT oil (1.0 mL/kg body weight) was administered to high-LCT diet (45% fat by energy, 4.73 kcal/g, Cat# D12451) (Research Diets Inc., New Brunswick, NJ, US)-fed, 6-week-old male WT mice and GIP KO mice once daily at 8:00 p.m. by oral gavage. In long-term high-LCT diet tolerance test using a CCK antagonist, drinking water or drinking water supplemented with the CCK antagonist proglumide (0.1 mg/mL, approximately 30 mg/kg/day) (Sigma- Aldrich Japan, Tokyo, Japan) was administered. Body weights were measured once a week. Insulin tolerance test (ITT) and oral glucose tolerance test (OGTT) were performed at weeks 10 and 12 of loading. Fat mass and energy expenditure were measured using computed tomography (CT) and an indirect calorimeter, respectively, at week 14 of loading.
+ Open protocol
+ Expand
2

Reagents for Chromatographic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were purchased: acetonitrile, isopropanol, and methanol from Optima Grade (Fisher Scientific, Waltham, MA, USA); high-purity formic acid (Thermo Scientific, Waltham, MA, USA); proglumide; and 4-nitrobenzoic acid (4-NBA) (Sigma-Aldrich, St. Louis, MI, USA).
+ Open protocol
+ Expand
3

Pharmacological agents dosages for in-vivo studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
DON (purity >98%) was obtained from Sigma-Aldrich (St. Louis, MA, USA). DON was dissolved in sterile phosphate buffered saline (PBS) containing 1% dimethyl sulfoxide (DMSO) and dissolved to 0.1, 0.5, 1, 2.5, and 5 mg/kg·bw. GIP (MedChemExpress; Trenton, NJ, USA), PYY, and CCK (Sigma-Aldrich; St. Louis, MO, USA) were respectively diluted in PBS, at a dose of 0.1 mg/kg·bw. GLP-1 (MedChemExpress) was made into a 0.01 mg/kg·bw solution with PBS. The PYY receptor antagonist JNJ-31020028, the CCK receptor antagonist Proglumide (Sigma-Aldrich), and GLP-1 receptor antagonist Exendin(9-39) were respectively dissolved in 100 μL sterile PBS, so that their final doses were 10, 200, or 0.1 mg/kg·bw. GIP receptor inhibition GIP(3-30)NH2 was synthesized by the Syn peptide (Shanghai, China), diluted with normal saline to 50 nm/kg·bw, and injected through the tail vein. According to the instructions of the reagent supplier, previous animal research and thesis data, the dosages of various pharmacological agents were selected [27 (link),31 (link),34 (link),35 (link)].
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of CCK Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The nonselective CCK receptor antagonist, proglumide, was purchased from Sigma and was resuspended in water. Immunohistochemistry reagents were purchased from Vector Laboratories. The rabbit polyclonal CCK-A receptor antibody was obtained from Pierce (PA-3116) and the goat polyclonal CCK-B receptor antibody (ab77077) from Abcam (Toronto, Canada). These CCK receptor antibodies react to both murine and human CCK-B receptors.
+ Open protocol
+ Expand
5

Investigating NMDA-Mediated Gastric Secretion

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the study of NMDA influence on stimulated GAS the following secretagogues were used, being injected i.p., intravenous (i.v.) and intraduodenal (i.d.): carbachol (10 µg/kg, i.p.), histamine (3 mg/kg, i.v.), pentagastrin (0.26 mg/kg, i.p.), cytisine (0.34 mg/kg, i.d., Sopharma, Bulgaria), neutral monocomponent human insulin Acrtapid MC (1.2 u/kg, i.v.), 2-deoxy-D-glucose (100 mg/kg, i.v.) from Sigma Aldrich, USA. The GAS blockers, pentamine (3.2 µg/kg, i.p.), atropine (1 g/kg, i.p.), gastrozepin (3 mg/kg, i.p.), proglumide (10 mg/kg, i.p.), and ranitidine (2 mg/kg, i.p.) were used at doses offered by the manufacturers; AP5 (50 µg/kg, i.p.) (Sigma Aldrich, USA). We used NMDA as an agonist of NMDARs (3 mg/kg, i.p.)27 (link) (Sigma Aldrich, USA). Prior to injections, the drugs were dissolved in 0.9% saline and then heated to 37 °C.
+ Open protocol
+ Expand
6

Cell Proliferation Assay with Glutamine Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded into each well of a 96-well plate (B16-F1 and A375 cells, 2 × 103 cells per well; A431 and HSC-1 cells, 4 × 103 cells per well). After overnight culture at 37 °C, the cells were treated with lorglumide (Abcam), proglumide (Sigma-Aldrich, St. Louis, MO), or loxiglumide (Sigma-Aldrich) for 48 hours. A total of 10 μl of water-soluble tetrazolium salt-8 (Dojindo Molecular Technologies, Kumamoto, Japan) was added to each well of a 96-well plate, and the cells were incubated for another 3 hours at 37 °C. Optical density was measured using an iMark Microplate Absorbance Reader (Bio-Rad Laboratory) at 450 nm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!